207 related articles for article (PubMed ID: 35691755)
21. Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer.
Seagle HM; Keller SR; Tavtigian SV; Horton C; Holowatyj AN
J Clin Oncol; 2023 Sep; 41(26):4279-4289. PubMed ID: 37319387
[TBL] [Abstract][Full Text] [Related]
22. Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients.
Jóri B; Kamps R; Xanthoulea S; Delvoux B; Blok MJ; Van de Vijver KK; de Koning B; Oei FT; Tops CM; Speel EJ; Kruitwagen RF; Gomez-Garcia EB; Romano A
Oncotarget; 2015 Dec; 6(38):41108-22. PubMed ID: 26517685
[TBL] [Abstract][Full Text] [Related]
23. Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program.
Jones JC; Golafshar MA; Coston TW; Rao R; Wysokinska E; Johnson E; Esplin ED; Nussbaum RL; Heald B; Klint M; Barrus K; Uson PL; Nguyen CC; Colon-Otero G; Bekaii-Saab TS; Dronca R; Kunze KL; Samadder NJ
Cureus; 2023 Apr; 15(4):e37428. PubMed ID: 37181954
[TBL] [Abstract][Full Text] [Related]
24. Somatic tumor testing implications for Lynch syndrome germline genetic testing.
Barrus K; Purington N; Chun N; Ladabaum U; Ford JM
Cancer Genet; 2022 Jun; 264-265():16-22. PubMed ID: 35286930
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
26. Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study.
Uson PLS; Samadder NJ; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Faigel DO; Fukami N; Pannala R; Kunze K; Golafshar M; Klint M; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T
Clin Transl Gastroenterol; 2021 Oct; 12(10):e00414. PubMed ID: 34620795
[TBL] [Abstract][Full Text] [Related]
27. Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
Hodan R; Rodgers-Fouche L; Arora S; Dominguez-Valentin M; Kanth P; Katona BW; Mraz KA; Roberts ME; Vilar E; Soto-Azghani CM; Brand RE; Esplin ED; Perez K
J Genet Couns; 2022 Aug; 31(4):949-955. PubMed ID: 35218578
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and spectrum of cancer predisposition germline mutations in young patients with the common late-onset cancers.
Hao S; Zhao X; Fan Y; Liu Z; Zhang X; Li W; Yuan H; Zhang J; Zhang Y; Ma T; Tao H
Cancer Med; 2023 Sep; 12(17):18394-18404. PubMed ID: 37610374
[TBL] [Abstract][Full Text] [Related]
29. Inherited predisposition to endometrial cancer: moving beyond Lynch syndrome.
Stadler ZK; Robson ME
Cancer; 2015 Mar; 121(5):644-7. PubMed ID: 25376647
[No Abstract] [Full Text] [Related]
30. Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer.
Kast K; Dobberschütz C; Sadowski CE; Pistorius S; Wimberger P
Arch Gynecol Obstet; 2016 Nov; 294(6):1299-1303. PubMed ID: 27535758
[TBL] [Abstract][Full Text] [Related]
31. Women with breast and uterine cancer are more likely to harbor germline mutations than women with breast or uterine cancer alone: A case for expanded gene testing.
Fulk K; Milam MR; Li S; Yussuf A; Black MH; Chao EC; LaDuca H; Stany MP
Gynecol Oncol; 2019 Mar; 152(3):612-617. PubMed ID: 30612783
[TBL] [Abstract][Full Text] [Related]
32. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
Singhal D; Hahn CN; Feurstein S; Wee LYA; Moma L; Kutyna MM; Chhetri R; Eshraghi L; Schreiber AW; Feng J; Wang PP; Babic M; Parker WT; Gao S; Moore S; Das S; Thomas D; Pattnaik S; Brown AL; D'Andrea RJ; Poplawski NK; Thomas D; Scott HS; Godley LA; Hiwase DK
Leukemia; 2021 Nov; 35(11):3245-3256. PubMed ID: 33850299
[TBL] [Abstract][Full Text] [Related]
33. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer.
Kumari N; Singh RK; Mishra SK; L R; Mohindra S; Krishnani N
Pathol Res Pract; 2021 Jan; 217():153309. PubMed ID: 33341547
[TBL] [Abstract][Full Text] [Related]
35. Germline PTEN mutations as a cause of early-onset endometrial cancer.
Blumenthal GM; Dennis PA
J Clin Oncol; 2008 May; 26(13):2234; author reply 2234. PubMed ID: 18445858
[No Abstract] [Full Text] [Related]
36. Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.
Kwong A; Shin VY; Chen J; Cheuk IWY; Ho CYS; Au CH; Chan KKL; Ngan HYS; Chan TL; Ford JM; Ma ESK
J Mol Diagn; 2020 Apr; 22(4):544-554. PubMed ID: 32068069
[TBL] [Abstract][Full Text] [Related]
37. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
Sorscher S; Ansley K; Delaney SD; Ramkissoon S
Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
39. Germline Genetic Mutations in Adult Patients with Sarcoma: Insight into the Middle East Genetic Landscape.
Abu-Hijlih R; Sharaf B; Salah S; Bani Hani H; Alqaisieh M; Alzibdeh A; Ababneh L; Mahafdah S; Abdel-Razeq H
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730621
[TBL] [Abstract][Full Text] [Related]
40. Frequency of actionable germline pathogenic variants identified through tumor next-generation sequencing in a gynecologic cancer cohort.
Karpel H; Manderski E; Pothuri B
Int J Gynecol Cancer; 2023 Jul; 33(7):1044-1050. PubMed ID: 36889816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
